P2-12-13: Topoisomerase 2 alpha (TOP2A) RNA Expression Provides Prognostic Information in Hormone Receptor Positive Breast Cancer That Is Complementary to a Simulated Algorithm for... von Sparano, JA, Goldstein, LJ, Davidson, NE, Sledge, Jr GW, Gray, R

Volltext

The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antago... von SWEENEY, Christopher J, MILLER, Kathy D, SISSONS, Sean E, NOZAKI, Shinichi, HEILMAN, Douglas K, JIANZHAO SHEN, SLEDGE, George W

Volltext

Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth von Nakshatri, Harikrishna, Bhat-Nakshatri, Poornima, Martin, Daniel A., Goulet, Robert J., Sledge, George W.

Volltext

Paclitaxel sensitivity of breast cancer cells with constitutively active NF-κB is enhanced by IκBα super-repressor and parthenolide von Patel, Nikhil M, Nozaki, Shinichi, Shortle, Nicholas H, Bhat-Nakshatri, Poornima, Newton, Thomas R, Rice, Susan, Gelfanov, Vasily, Boswell, Scott H, Goulet, Robert J, Sledge, George W, Nakshatri, Harikrishna

Volltext

Repression of GADD153/CHOP by NF-κB : a possible cellular defense against endoplasmic reticulum stress-induced cell death von NOZAKI, Shinichi, SLEDGE, George W, NAKSHATRI, Harikrishna

Volltext

GRB7 -dependent pathways are potential therapeutic targets in triple-negative breast cancer von Sparano, JA, Gray, R, Goldstein, LJ, Childs, BH, Bugarini, R, Rowley, S, Baker, J, Shak, S, Badve, S, Baehner, FL, Perez, EA, Shulman, LN, Martino, S, Sledge Jr, GW, Davidson, NE

Volltext

Cancer Cell-Derived Interleukin 1α Contributes to Autocrine and Paracrine Induction of Pro-metastatic Genes in Breast Cancer von Nozaki, Shinichi, Sledge, George W., Nakshatri, Harikrishna

Volltext

A Phase I Trial of Recombinant Human Interleukin-11 (Neumega rhIL-11 Growth Factor) in Women With Breast Cancer Receiving Chemotherapy von Gordon, Michael S., McCaskill-Stevens, Worta J., Battiato, Linda A., Loewy, John, Loesch, David, Breeden, Elyse, Hoffman, Ron, Beach, Kathleen J., Kuca, Bernice, Kaye, James, Sledge, George W.

Volltext

What Is the Optimum Duration of Tamoxifen Adjuvant Therapy? von Sledge, Jr, GW

Volltext

What New Drugs, Biologics, and Treatment Approaches Show Promise in Breast Cancer? von Hortobagyi, GN, Sledge, Jr, GW, Rowinsky, EK

Volltext

A comparative proteomic study to characterize the vinblastine resistance in human ovarian cancer cells von Brown, Dawn P. G., Gökmen-Polar, Yesim, Jiang, Li, Tan, Jian, Ringham, Heather, Janecki, Dariusz J., Qi, Guihong, Witzmann, Frank A., Sledge Jr, George W., Wang, Mu

Volltext

What are the Roles of the Taxanes in Breast Cancer von Sledge, Jr, GW, Rowinsky, EK, Hortobagyi, GN, Vaughan, W, Horton, J

Volltext

Analysis of Phorbol Ester Stimulated Human Megakaryocyte Development von Roth, Bruce J., Sledge, George W., Straneva, John E., Brandt, John, Goheen, Michael, Hoffman, Ronald

Volltext

Binding of insulin-like growth factors to tera-2 human embryonal carcinoma cells during differentiation von FLECK, J. F, SLEDGE, G. W, BENENATI, S. V, FROLIK, C. A, ROTH, B. J, HIRSCH, K. S

Volltext

Analysis of phorbol ester stimulated human megakaryocyte development von Roth, BJ, Sledge, GW Jr, Straneva, JE, Brandt, J, Goheen, M, Hoffman, R

Volltext

Monoclonal antibody storage conditions, and concentration effects on immunohistochemical specificity von Ciocca, DR, Adams, DJ, Bjercke, RJ, Sledge, GW, Jr, Edwards, DP, Chamness, GC, McGuire, WL

Volltext

Monoclonal antibody identification and characterization of a M sub(r) 43,000 membrane glycoprotein associated with human breast cancer von Edwards, D P, Grzyb, K T, Dressler, L G, Mansel, R E, Zava, D T, Sledge, GW Jr, McGuire, W L

Volltext

Unusual distribution of chromosome 12 in a testicular germ-cell tumor cell line (833K) and its cisplatin-resistant derivative (64CP9) von Reilly, Patricia A., Heerema, Nyla A., Sledge, George W., Palmer, Catherine G.

Volltext

Redefining the Target: Chemotherapeutics as Antiangiogenics von MILLER, Kathy D, SWEENEY, Christopher J, SLEDGE, George W

Volltext

Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer von GORDON, M. S, MARGOLIN, K, TALPAZ, M, SLEDGE, G. W, HOLMGREN, E, BENJAMIN, R, STALTER, S, SHAK, S, ADELMAN, D. C

Volltext